Nuclear Imaging Devices Market

Nuclear Imaging Devices Market {Product Type: PET Devices (Standalone PET, PET/CT, PET/MRI), SPECT Devices (Standalone SPECT, SPECT/CT, SPECT/MRI), and Planar Imaging Devices} - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Nuclear Imaging Devices Market Outlook 2031

  • The global industry was valued at US$ 2.6 Bn in 2022
  • It is projected to grow at a CAGR of 4.8% from 2023 to 2031 and reach more than US$ 4.0 Bn by the end of 2031

Analysts’ Viewpoint

The global nuclear imaging devices market is poised for substantial growth, driven by key factors shaping its trajectory. The increase in prevalence of chronic diseases, such as cancer and cardiovascular disorders, is a major factor propelling the nuclear imaging devices industry growth.

Technological advancements, particularly in hybrid imaging modalities including SPECT/CT and PET/CT, enhance the diagnostic accuracy and expand the clinical applications of nuclear imaging devices.

Increase in investments in research and development activities are fostering the continuous evolution of imaging technologies, offering lucrative opportunities for market expansion. Furthermore, the rising geriatric population, which is more prone to various diseases requiring nuclear imaging for diagnosis, fuels market statistics.

The adoption of nuclear imaging devices is expected to increase as healthcare infrastructures worldwide continue to modernize.

Nuclear Imaging Devices Market

Market Introduction

Nuclear imaging devices play a crucial role in non-invasive imaging, offering valuable insights into physiological functions for a range of medical conditions and aid in early disease detection. Increase in prevalence of chronic diseases, rise in geriatric population, and continuous technological advancements in imaging modalities are key factors propelling the market.

Introduction of hybrid imaging technologies, such as SPECT/CT and PET/CT, has revolutionized diagnostic capabilities, providing enhanced accuracy and expanded clinical applications. Nuclear imaging devices are integral in early disease detection and monitoring, contributing to improved patient outcomes.

With a proactive approach to diagnostic precision, the global nuclear imaging devices market stands at the forefront of medical imaging innovation, offering a promising future for enhanced healthcare diagnostics.

Launch of Newer Radiotracers and Biomarkers for Disease Assessment Propelling Nuclear Imaging Devices Market Size

The continual introduction of new radiotracers and tailored biomarkers is broadening the scope of molecular imaging and driving market development.

Pharmaceutical corporations and university research institutions are significantly investing in the development of radiolabeled substances that can better evaluate disease states and therapy responses. For example, radiolabeled tracers tailored for prostate-specific membrane antigen (PSMA) have showed tremendous promise in identifying metastatic prostate cancer with more sensitivity than traditional methods.This has spurred growing demand for hybrid PET/CT scans.

The approval of new tracers for cardiovascular applications, such as 18F-sodium fluoride and 18F-flurpiridaz F 18, is proving useful in imaging vascular inflammation/calcification and stent patency, facilitating risk prediction and intervention planning.

Furthermore, advances in targeted radionuclide treatment are connecting biomarkers such as PSMA and receptors to therapeutic radiotracers, indicating individualized tailored radiation with little side effects. Innovation is driving upgrade cycles and new purchases of improved PET/SPECT/hybrid equipment, thus bolstering the nuclear imaging devices market value.

High Demand for SPECT Devices

The nuclear imaging devices market segmentation in terms of product type includes PET devices, SPECT devices, and planar imaging devices. The SPECT devices segment held significant market share in 2022. SPECT devices play a pivotal role in nuclear medicine by providing detailed three-dimensional images of internal organs and tissues, facilitating accurate diagnosis and treatment planning.

SPECT is particularly effective in imaging bone, cardiac, and neurological conditions, offering a comprehensive and functional view of physiological processes. The diagnostic capabilities of SPECT devices contribute to their widespread adoption in oncology, cardiology, and neurology, addressing a spectrum of medical conditions.

The leading position of SPECT devices underscores their critical role in providing clinicians with valuable insights for informed decision-making. As the demand for precise and non-invasive diagnostic solutions continues to grow, SPECT devices maintain their leadership, solidifying their position as a cornerstone in nuclear imaging devices industry growth.

Oncology Applications Gaining Traction

According to the nuclear imaging devices market analysis, the oncology segment is projected to account for dominant share based on application, during the forecast period.

Oncology applications utilize nuclear imaging technologies such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT) to visualize and analyze the metabolic and functional activity of tissues, aiding in the detection and characterization of tumors.

Nuclear imaging devices offer unparalleled precision in oncology, allowing for early and accurate identification of cancerous lesions. PET scans, for instance, can highlight areas with increased metabolic activity, aiding in staging and determining the extent of cancer spread. Additionally, SPECT imaging provides valuable insights into the functional characteristics of tumors.

Extensive Usage of Imaging Technology in Hospitals

As per the nuclear imaging devices market report, the hospitals segment is emerging as a robust end-user segment.

Nuclear imaging devices, including positron emission tomography (PET) and single-photon emission computed tomography (SPECT), find extensive use in hospitals for their capability to provide detailed and accurate images of physiological processes, aiding in the diagnosis and monitoring of various medical conditions.

Larger hospitals often have the financial capacity to invest in state-of-the-art medical infrastructure, including advanced imaging technologies. This positions them as key contributors, boosting the nuclear imaging devices market revenue.

Regional Outlook of Global Nuclear Imaging Devices Industry

According to the latest nuclear imaging devices market forecast, North America dominated the landscape, with the United States leading the region in 2022. The U.S. stands at the forefront of advancements in healthcare technology, boasting a sophisticated healthcare infrastructure and a robust research and development ecosystem.

The high prevalence of chronic diseases, coupled with a proactive approach to adopting innovative medical imaging solutions, positions the U.S. as a key contributor to the regional market's dominance.

A rising geriatric population and increasing incidence of diseases that necessitate advanced diagnostic capabilities further boosts market dynamics. The U.S. healthcare sector's continuous investments in cutting-edge technologies, coupled with favorable reimbursement policies, enable the widespread adoption of nuclear imaging devices.

Analysis of Key Players

The global nuclear imaging devices market is consolidated, with the presence of a small number of leading players. Expansion of product portfolio and mergers & acquisitions are the key strategies implemented by leading players.

Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers AG, Canon Medical Systems Corporation, Shimadzu Corporation, MR Solutions, Neusoft Medical Systems Co., Ltd., Mediso Ltd., and MiE GmbH, are the prominent nuclear imaging devices manufacturers.

Key Developments

  • In June 2023, GE Healthcare showcased the integration of its advanced AIR technologies with the SIGNA PET/MR AIR system, to enhance diagnostic precision, simplify treatment evaluation, while elevating patient comfort, at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2023 annual meeting
  • In June 2023, Siemens Healthineers debuted the Biograph Vision.X, a new PET/CT scanner that builds on the established performance of the Biograph Vision and delivers a time of flight (TOF) of 178 picoseconds (ps)-reportedly the industry’s fastest TOF. The announcement was made at the 2023 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
  • In October 2022, GE Healthcare introduced Omni Legend, an innovative all-digital PET-CT system that offers higher sensitivity, faster procedural time, improved operational efficiency, and enhanced patient outcome.
  • In June 2022, Siemens Healthineers AG received clearance for its Symbia Pro.specta by the Food and Drug Administration. The versatile Symbia Pro.specta SPECT/CT system combines cutting-edge CT and SPECT imaging technologies. The company's operational capabilities and growth opportunities in the market were enhanced by these product approvals.

Each of these players has been profiled in the nuclear imaging devices market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Global Nuclear Imaging Devices Market Snapshot

Attribute Detail
Market Size Value in 2022 US$ 2.6 Bn
Market Forecast Value in 2031 US$ 4.0 Bn
Growth Rate (CAGR) 4.8%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Units US$ Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Product Type
    • PET Devices
      • Standalone PET
      • PET/CT
      • PET/MRI
    • SPECT Devices
      • Standalone SPECT
      • SPECT/CT
      • SPECT/MRI
    • Planar Imaging Devices
  • Application
    • Oncology
    • Cardiology
    • Neurology
    • Others (Nephrology, Immunology, etc.)
  • End-user
    • Hospitals
    • Imaging Centers
    • Academic and Research Centers
    • Others (Clinics, CROs, etc.)
Regions Covered
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC Countries
Companies Profiled
  • Koninklijke Philips N.V.
  • GE Healthcare
  • Siemens Healthineers AG
  • Canon Medical Systems Corporation
  • Shimadzu Corporation
  • MR Solutions
  • Neusoft Medical Systems Co., Ltd.
  • Mediso Ltd.
  • MiE GmbH
  • Other Players
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global nuclear imaging devices market in 2022?

It was valued at US$ 2.6 Bn in 2022

How big will the nuclear imaging devices industry be by 2031?

It is projected to reach more than US$ 4.0 Bn by the end of 2031

What will be the CAGR of the nuclear imaging devices business during the forecast period?

The CAGR is anticipated to be 4.8% from 2023 to 2031

Which nuclear imaging devices segment accounted for leading share in 2022?

Based on product type, the SPECT devices segment accounted for leading share in 2022

Which region is projected to account for major share in the nuclear imaging devices landscape during the forecast period?

North America is anticipated to account for leading share during the forecast period

Who are the prominent nuclear imaging devices players?

Neusoft Medical Systems Co., Ltd., Canon Medical Systems Corporation, Shimadzu Corporation, Koninklijke Philips N.V., GE Healthcare, and Siemens Healthineers AG.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Nuclear Imaging Devices Market

4. Market Overview

    4.1. Introduction

        4.1.1. Segment Definition

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Nuclear Imaging Device Market Analysis and Forecasts, 2017 - 2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Regulatory Scenario

    5.2. Technological Advancements

    5.3. Key Industry Events

    5.4. COVID-19 Pandemic Impact on Industry

6. Global Nuclear Imaging Devices Market Analysis and Forecast, by Product Type

    6.1. Introduction & Definition

    6.2. Key Findings/Developments

    6.3. Market Value Forecast, by Product Type, 2017 - 2031

        6.3.1. PET Devices

            6.3.1.1. Standalone PET

            6.3.1.2. PET/CT

            6.3.1.3. PET/MRI

        6.3.2. SPECT Devices

            6.3.2.1. Standalone SPECT

            6.3.2.2. SPECT/CT

            6.3.2.3. SPECT/MRI

        6.3.3. Planar Imaging Devices

    6.4. Market Attractiveness Analysis, by Product Type

7. Global Nuclear Imaging Devices Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Key Findings/Developments

    7.3. Market Value Forecast, by Application, 2017 - 2031

        7.3.1. Oncology

        7.3.2. Cardiology

        7.3.3. Neurology

        7.3.4. Others (Nephrology, Immunology, etc.)

    7.4. Market Attractiveness Analysis, by Application

8. Global Nuclear Imaging Devices Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings/Developments

    8.3. Market Value Forecast, by End-user, 2017 - 2031

        8.3.1. Hospitals

        8.3.2. Imaging Centers

        8.3.3. Academic and Research Centers

        8.3.4. Others (Clinics, CROs, etc.)

    8.4. Market Attractiveness Analysis, by End-user

9. Global Nuclear Imaging Devices Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region, 2017 - 2031

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Region

10. North America Nuclear Imaging Devices Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Product Type, 2017 - 2031

        10.2.1. PET Devices

            10.2.1.1. Standalone PET

            10.2.1.2. PET/CT

            10.2.1.3. PET/MRI

        10.2.2. SPECT Devices

            10.2.2.1. Standalone SPECT

            10.2.2.2. SPECT/CT

            10.2.2.3. SPECT/MRI

        10.2.3. Planar Imaging Devices

    10.3. Market Value Forecast, by Application, 2017 - 2031

        10.3.1. Oncology

        10.3.2. Cardiology

        10.3.3. Neurology

        10.3.4. Others (Nephrology, Immunology, etc.)

    10.4. Market Value Forecast, by End-user, 2017 - 2031

        10.4.1. Hospitals

        10.4.2. Imaging Centers

        10.4.3. Academic and Research Centers

        10.4.4. Others (Clinics, CROs, etc.)

    10.5. Market Value Forecast, by Country, 2017 - 2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Product Type

        10.6.2. By Application

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Nuclear Imaging Devices Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product Type, 2017 - 2031

        11.2.1. PET Devices

            11.2.1.1. Standalone PET

            11.2.1.2. PET/CT

            11.2.1.3. PET/MRI

        11.2.2. SPECT Devices

            11.2.2.1. Standalone SPECT

            11.2.2.2. SPECT/CT

            11.2.2.3. SPECT/MRI

        11.2.3. Planar Imaging Devices

    11.3. Market Value Forecast, by Application, 2017 - 2031

        11.3.1. Oncology

        11.3.2. Cardiology

        11.3.3. Neurology

        11.3.4. Others (Nephrology, Immunology, etc.)

    11.4. Market Value Forecast, by End-user, 2017 - 2031

        11.4.1. Hospitals

        11.4.2. Imaging Centers

        11.4.3. Academic and Research Centers

        11.4.4. Others (Clinics, CROs, etc.)

    11.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031

        11.5.1. Germany

        11.5.2. UK

        11.5.3. France

        11.5.4. Italy

        11.5.5. Spain

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Product Type

        11.6.2. By Application

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Nuclear Imaging Devices Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product Type, 2017 - 2031

        12.2.1. PET Devices

            12.2.1.1. Standalone PET

            12.2.1.2. PET/CT

            12.2.1.3. PET/MRI

        12.2.2. SPECT Devices

            12.2.2.1. Standalone SPECT

            12.2.2.2. SPECT/CT

            12.2.2.3. SPECT/MRI

        12.2.3. Planar Imaging Devices

    12.3. Market Value Forecast, by Application, 2017 - 2031

        12.3.1. Oncology

        12.3.2. Cardiology

        12.3.3. Neurology

        12.3.4. Others (Nephrology, Immunology, etc.)

    12.4. Market Value Forecast, by End-user, 2017 - 2031

        12.4.1. Hospitals

        12.4.2. Imaging Centers

        12.4.3. Academic and Research Centers

        12.4.4. Others (Clinics, CROs, etc.)

    12.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By Product Type

        12.6.2. By Application

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Nuclear Imaging Devices Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product Type, 2017 - 2031

        13.2.1. PET Devices

            13.2.1.1. Standalone PET

            13.2.1.2. PET/CT

            13.2.1.3. PET/MRI

        13.2.2. SPECT Devices

            13.2.2.1. Standalone SPECT

            13.2.2.2. SPECT/CT

            13.2.2.3. SPECT/MRI

        13.2.3. Planar Imaging Devices

    13.3. Market Value Forecast, by Application, 2017 - 2031

        13.3.1. Oncology

        13.3.2. Cardiology

        13.3.3. Neurology

        13.3.4. Others (Nephrology, Immunology, etc.)

    13.4. Market Value Forecast, by End-user, 2017 - 2031

        13.4.1. Hospitals

        13.4.2. Imaging Centers

        13.4.3. Academic and Research Centers

        13.4.4. Others (Clinics, CROs, etc.)

    13.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By Product Type

        13.6.2. By Application

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Nuclear Imaging Devices Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Product Type, 2017 - 2031

        14.2.1. PET Devices

            14.2.1.1. Standalone PET

            14.2.1.2. PET/CT

            14.2.1.3. PET/MRI

        14.2.2. SPECT Devices

            14.2.2.1. Standalone SPECT

            14.2.2.2. SPECT/CT

            14.2.2.3. SPECT/MRI

        14.2.3. Planar Imaging Devices

    14.3. Market Value Forecast, by Application, 2017 - 2031

        14.3.1. Oncology

        14.3.2. Cardiology

        14.3.3. Neurology

        14.3.4. Others (Nephrology, Immunology, etc.)

    14.4. Market Value Forecast, by End-user, 2017 - 2031

        14.4.1. Hospitals

        14.4.2. Imaging Centers

        14.4.3. Academic and Research Centers

        14.4.4. Others (Clinics, CROs, etc.)

    14.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis

        14.6.1. By Product Type

        14.6.2. By Application

        14.6.3. By End-user

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player – Competition Matrix (By Tier and Size of Companies)

    15.2. Market Share Analysis, by Company (2022)

    15.3. Company Profiles

        15.3.1. Koninklijke Philips N.V.

            15.3.1.1. Company Overview

            15.3.1.2. Financial Overview

            15.3.1.3. Product Portfolio

            15.3.1.4. Business Strategies

            15.3.1.5. Recent Developments

        15.3.2. GE Healthcare

            15.3.2.1. Company Overview

            15.3.2.2. Financial Overview

            15.3.2.3. Product Portfolio

            15.3.2.4. Business Strategies

            15.3.2.5. Recent Developments

        15.3.3. Canon Medical Systems Corporation

            15.3.3.1. Company Overview

            15.3.3.2. Financial Overview

            15.3.3.3. Product Portfolio

            15.3.3.4. Business Strategies

            15.3.3.5. Recent Developments

        15.3.4. Siemens Healthineers AG

            15.3.4.1. Company Overview

            15.3.4.2. Financial Overview

            15.3.4.3. Product Portfolio

            15.3.4.4. Business Strategies

            15.3.4.5. Recent Developments

        15.3.5. Shimadzu Corporation

            15.3.5.1. Company Overview

            15.3.5.2. Financial Overview

            15.3.5.3. Product Portfolio

            15.3.5.4. Business Strategies

            15.3.5.5. Recent Developments

        15.3.6. MR Solutions

            15.3.6.1. Company Overview

            15.3.6.2. Financial Overview

            15.3.6.3. Product Portfolio

            15.3.6.4. Business Strategies

            15.3.6.5. Recent Developments

        15.3.7. Neusoft Medical Systems Co., Ltd.

            15.3.7.1. Company Overview

            15.3.7.2. Financial Overview

            15.3.7.3. Product Portfolio

            15.3.7.4. Business Strategies

            15.3.7.5. Recent Developments

        15.3.8. Mediso Ltd.

            15.3.8.1. Company Overview

            15.3.8.2. Financial Overview

            15.3.8.3. Product Portfolio

            15.3.8.4. Business Strategies

            15.3.8.5. Recent Developments

        15.3.9. MiE GmbH

            15.3.9.1. Company Overview

            15.3.9.2. Financial Overview

            15.3.9.3. Product Portfolio

            15.3.9.4. Business Strategies

            15.3.9.5. Recent Developments

List of Tables

Table 01: Global Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Product Type, 2017 - 2031

Table 02: Global Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by PET Devices, 2017 - 2031

Table 03: Global Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by SPECT Devices, 2017 - 2031

Table 04: Global Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Application, 2017 - 2031

Table 05: Global Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by End-user, 2017 - 2031

Table 06: Global Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Region, 2017 - 2031

Table 07: North America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Product Type, 2017 - 2031

Table 08: North America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by PET Devices, 2017 - 2031

Table 09: North America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by SPECT Devices, 2017 - 2031

Table 10: North America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Application, 2017 - 2031

Table 11: North America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by End-user, 2017 - 2031

Table 12: North America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Country, 2017 - 2031

Table 13: Europe Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Product Type, 2017 - 2031

Table 14: Europe Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by PET Devices, 2017 - 2031

Table 15: Europe Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by SPECT Devices, 2017 - 2031

Table 16: Europe Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Application, 2017 - 2031

Table 17: Europe Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by End-user, 2017 - 2031

Table 18: Europe Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2031

Table 19: Asia Pacific Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Product Type, 2017 - 2031

Table 20: Asia Pacific Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by PET Devices, 2017 - 2031

Table 21: Asia Pacific Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by SPECT Devices, 2017 - 2031

Table 22: Asia Pacific Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Application, 2017 - 2031

Table 23: Asia Pacific Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by End-user, 2017 - 2031

Table 24: Asia Pacific Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2031

Table 25: Latin America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Product Type, 2017 - 2031

Table 26: Latin America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by PET Devices, 2017 - 2031

Table 27: Latin America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by SPECT Devices, 2017 - 2031

Table 28: Latin America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Application, 2017 - 2031

Table 29: Latin America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by End-user, 2017 - 2031

Table 30: Latin America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2031

Table 31: Middle East & Africa Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Product Type, 2017 - 2031

Table 32: Middle East & Africa Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by PET Devices, 2017 - 2031

Table 33: Middle East & Africa Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by SPECT Devices, 2017 - 2031

Table 34: Middle East & Africa Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Application, 2017 - 2031

Table 35: Middle East & Africa Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by End-user, 2017 - 2031

Table 36: Middle East & Africa Nuclear Imaging Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017

List of Figures

Figure 01: Global Nuclear Imaging Devices Market Value (US$ Mn) Forecast, 2017 - 2031

Figure 02: Global Nuclear Imaging Devices Market Value Share Analysis, by Product Type, 2022 - 2031

Figure 03: Global Nuclear Imaging Devices Market Value Share Analysis, by PET Devices, 2022 - 2031

Figure 04: Global Nuclear Imaging Devices Market Value Share Analysis, by Standalone PET, 2022 - 2031

Figure 05: Global Nuclear Imaging Devices Market Value Share Analysis, by PET/CT, 2022 - 2031

Figure 06: Global Nuclear Imaging Devices Market Value Share Analysis, by PET/MRI, 2022 - 2031

Figure 07: Global Nuclear Imaging Devices Market Value Share Analysis, by SPECT Devices, 2022 - 2031

Figure 08: Global Nuclear Imaging Devices Market Value Share Analysis, by Standalone SPECT, 2022 - 2031

Figure 09: Global Nuclear Imaging Devices Market Value Share Analysis, by SPECT/CT, 2022 - 2031

Figure 10: Global Nuclear Imaging Devices Market Value Share Analysis, by SPECT/MRI, 2022 - 2031

Figure 11: Global Nuclear Imaging Devices Market Value Share Analysis, by Planar Imaging Devices, 2022 - 2031

Figure 12: Global Nuclear Imaging Devices Market Attractiveness Analysis, by Product Type, 2023 - 2031

Figure 13: Global Nuclear Imaging Devices Market Value Share Analysis, by Application 2022 - 2031

Figure 14: Global Nuclear Imaging Devices Market Value Share Analysis, by Oncology, 2022 - 2031

Figure 15: Global Nuclear Imaging Devices Market Value Share Analysis, by Cardiology, 2022 - 2031

Figure 16: Global Nuclear Imaging Devices Market Value Share Analysis, by Neurology, 2022 - 2031

Figure 17: Global Nuclear Imaging Devices Market Value Share Analysis, by Others (Nephrology, Immunology, etc.), 2022 - 2031

Figure 18: Global Nuclear Imaging Devices Market Attractiveness Analysis, by Application, 2023 - 2031

Figure 19: Global Nuclear Imaging Devices Market Value Share Analysis, by End-user, 2022 - 2031

Figure 20: Global Nuclear Imaging Devices Market Value Share Analysis, by Hospitals, 2022 - 2031

Figure 21: Global Nuclear Imaging Devices Market Value Share Analysis, by Imaging Centers, 2022 - 2031

Figure 22: Global Nuclear Imaging Devices Market Value Share Analysis, by Academic and Research Centers, 2022 - 2031

Figure 23: Global Nuclear Imaging Devices Market Value Share Analysis, by Others (Clinics, CROs, etc.), 2022 - 2031

Figure 24: Global Nuclear Imaging Devices Market Attractiveness Analysis, by End-user, 2023 - 2031

Figure 25: Global Nuclear Imaging Devices Market Value Share Analysis, by Region, 2022 - 2031

Figure 26: Global Nuclear Imaging Devices Market Attractiveness Analysis, by Region, 2023 - 2031

Figure 27: North America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, 2017 - 2031

Figure 28: North America Nuclear Imaging Devices Market Value Share Analysis, by Product Type, 2022 - 2031

Figure 29: North America Nuclear Imaging Devices Market Attractiveness Analysis, by Product Type, 2023 - 2031

Figure 30: North America Nuclear Imaging Devices Market Value Share Analysis, by Application, 2022 - 2031

Figure 31: North America Nuclear Imaging Devices Market Attractiveness Analysis, by Application, 2023 - 2031

Figure 32: North America Nuclear Imaging Devices Market Value Share Analysis, by End-user, 2022 - 2031

Figure 33: North America Nuclear Imaging Devices Market Attractiveness Analysis, by End-user, 2023 - 2031

Figure 34: North America Nuclear Imaging Devices Market Value Share Analysis, by Country, 2022 - 2031

Figure 35: North America Nuclear Imaging Devices Market Attractiveness Analysis, by Country, 2023 - 2031

Figure 36: Europe Nuclear Imaging Devices Market Value (US$ Mn) Forecast, 2017 - 2031

Figure 37: Europe Nuclear Imaging Devices Market Value Share Analysis, by Product Type, 2022 - 2031

Figure 38: Europe Nuclear Imaging Devices Market Attractiveness Analysis, by Product Type, 2023 - 2031

Figure 39: Europe Nuclear Imaging Devices Market Value Share Analysis, by Application, 2022 - 2031

Figure 40: Europe Nuclear Imaging Devices Market Attractiveness Analysis, by Application, 2023 - 2031

Figure 41: Europe Nuclear Imaging Devices Market Value Share Analysis, by End-user, 2022 - 2031

Figure 42: Europe Nuclear Imaging Devices Market Attractiveness Analysis, by End-user, 2023 - 2031

Figure 43: Europe Nuclear Imaging Devices Market Value Share Analysis, by Country/Sub-region, 2022 - 2031

Figure 44: Europe Nuclear Imaging Devices Market Attractiveness Analysis, by Country/Sub-region, 2023 - 2031

Figure 45: Asia Pacific Nuclear Imaging Devices Market Value (US$ Mn) Forecast, 2017 - 2031

Figure 46: Asia Pacific Nuclear Imaging Devices Market Value Share Analysis, by Product Type, 2022 - 2031

Figure 47: Asia Pacific Nuclear Imaging Devices Market Attractiveness Analysis, by Product Type, 2023 - 2031

Figure 48: Asia Pacific Nuclear Imaging Devices Market Value Share Analysis, by Application 2022 - 2031

Figure 49: Asia Pacific Nuclear Imaging Devices Market Attractiveness Analysis, by Application, 2023 - 2031

Figure 50: Asia Pacific Nuclear Imaging Devices Market Value Share Analysis, by End-user, 2022 - 2031

Figure 51: Asia Pacific Nuclear Imaging Devices Market Attractiveness Analysis, by End-user, 2023 - 2031

Figure 52: Asia Pacific Nuclear Imaging Devices Market Value Share Analysis, by Country/Sub-region, 2022 - 2031

Figure 53: Asia Pacific Nuclear Imaging Devices Market Attractiveness Analysis, by Country/Sub-region, 2023 - 2031

Figure 54: Latin America Nuclear Imaging Devices Market Value (US$ Mn) Forecast, 2017 - 2031

Figure 55: Latin America Nuclear Imaging Devices Market Value Share Analysis, by Product Type, 2022 - 2031

Figure 56: Latin America Nuclear Imaging Devices Market Attractiveness Analysis, by Product Type, 2023 - 2031

Figure 57: Latin America Nuclear Imaging Devices Market Value Share Analysis, by Application, 2022 - 2031

Figure 58: Latin America Nuclear Imaging Devices Market Attractiveness Analysis, by Application, 2023 - 2031

Figure 59: Latin America Nuclear Imaging Devices Market Value Share Analysis, by End-user, 2022 - 2031

Figure 60: Latin America Nuclear Imaging Devices Market Attractiveness Analysis, by End-user, 2023 - 2031

Figure 61: Latin America Nuclear Imaging Devices Market Value Share Analysis, by Country/Sub-region, 2022 - 2031

Figure 62: Latin America Nuclear Imaging Devices Market Attractiveness Analysis, by Country/Sub-region, 2023 - 2031

Figure 63: Middle East & Africa Nuclear Imaging Devices Market Value (US$ Mn) Forecast, 2017 - 2031

Figure 64: Middle East & Africa Nuclear Imaging Devices Market Value Share Analysis, by Product Type, 2022 - 2031

Figure 65: Middle East & Africa Nuclear Imaging Devices Market Attractiveness Analysis, by Product Type, 2023 - 2031

Figure 66: Middle East & Africa Nuclear Imaging Devices Market Value Share Analysis, by Application, 2022 - 2031

Figure 67: Middle East & Africa Nuclear Imaging Devices Market Attractiveness Analysis, by Application, 2023 - 2031

Figure 68: Middle East & Africa Nuclear Imaging Devices Market Value Share Analysis, by End-user, 2022 - 2031

Figure 69: Middle East & Africa Nuclear Imaging Devices Market Attractiveness Analysis, by End-user, 2023 - 2031

Figure 70: Middle East & Africa Nuclear Imaging Devices Market Value Share Analysis, by Country/Sub-region, 2022 - 2031

Figure 71: Middle East & Africa Nuclear Imaging Devices Market Attractiveness Analysis, by Country/Sub-region, 2023 - 2031

Figure 72: Global Nuclear Imaging Devices Market Share Analysis, by Company, 2022

Copyright © Transparency Market Research, Inc. All Rights reserved